Nitric oxide deficiency in chronic renal disease

European Journal of Clinical Pharmacology

Volumn 62, Issue 1, 2006, Pages 123-130

  Baylis, Chris ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Asymmetric dimethylarginine (ADMA); L arginine transport; Renal neuronal nitric oxide synthase

Indexed keywords

ARGININE; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXIDIZING AGENT;

AMINO ACID TRANSPORT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; UREMIA; METABOLIC DISORDER; NITRIC OXIDE DEFICIENCY; SYNTHESIS;

EID: 33344472436     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0003-0     Document Type: Conference Paper

References (43)

1. Zatz R, Baylis C (1998) Chronic nitric oxide inhibition model six years on. Hypertension 32:958-964
2. Kone BC, Baylis C (1997) Biosynthesis and homeostatic roles of nitric oxide in the kidney. Editorial review. Am J Physiol 272:F561-F578
3. Schmidt R, Domico J, Samsell L, Yokota S, Tracy T, Sorkin M, Engels K, Baylis C (1999) Indices of activity of the nitric oxide system in patients on hemodialysis. Am J Kidney Dis 34:228-234
4. Schmidt RJ, Yokota S, Tracy TS, Sorkin MI, Baylis C (1999) Nitric oxide production is low in end stage renal disease patients on peritoneal dialysis. Am J Physiol 276:F794-F797
5. Schmidt RJ, Baylis C (2000) Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261-1266
6. x) levels in plasma and urine: what does this measure tell us about the activity of the endogenous nitric oxide? Curr Opin Nephrol Hypertens 7:59-62
7. Slum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G, Grosskopf I, Kaplan E, Silverberg D, Cabili S, Iaina A (1998) Low nitric oxide production in patients with chronic renal failure. Nephron 79:265-268
8. Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, Kastelein J, Versluis K, Lagerwerf F, van Rijn H, Koomans H, Rabelink T (1999) Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19:1168-1172
9. Lau T, Owen W, Yu YM, Noviski N, Lyons J, Zurakowski D, Tsay R, Ajami A, Young VR, Castillo L (2000) Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest 105:1217-1225
10. Erdely A, Freshour G, Smith C, Engels K, Olson J, Baylis C (2003) Protection against puromycin aminonucleoside (PAN) induced chronic renal disease (CRD) in the Wistar Furth (WF). J Am Soc Nephrol 14:155A
11. Erdely A, Greenfeld Z, Wagner L, Baylis C (2003) Sexual dimorphism in the aging kidney; inverse relationship between injury and nitric oxide system. Kidney Int 63:1021-1026
12. Erdely A, Wagner L, Muller V, Szabo A, Baylis C (2003) Protection of Wistar Furth rat from chronic renal disease is associated with maintained renal nitric oxide synthase vs. Sprague Dawley. J Am Soc Nephrol 14:2526-2533
13. Wagner L, Klein J, Sands J, Baylis C (2002) Urea transporters are widely distributed in endothelial cells and mediate inhibition of L-arginine transport. Am J Physiol 283:F578-F582
14. Xiao S, Schmidt RJ, Baylis C (2000) Plasma from ESRD patients inhibits nitric oxide synthase (NOS) activity in cultured human and bovine endothelial cells. Acta Physiol Scand 168: 175-179
15. Arnal JF, Warin L, Michel JB (1992) Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90: 647-652
16. Morris SM Jr (2000) Regulation of arginine availability and its impact on NO synthesis. In: Ignarro LJ (ed) Nitric oxide, biology and pathobiology. Academic, San Diego, pp 187-197
17. Mistry S, Greenfeld Z, Morris S, Baylis C (2002) The "intestinal- renal" arginine biosynthetic axis in the aging rat. Mech Age Dev 123:1159-1165
18. Xiao S, Wagner L, Baylis C (2001) Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells. Am J Physiol 49:F989-F995
19. McDonald KK, Zharikov S, Block ER, Kilberg MS (1997) A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J Biol Chem 272:31213-31216
20. Vallance P, Leon A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575
21. G-dimethyl-L arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8:1437-1442
22. Pettersson A, Uggla L, Bachman V (1997) Determination of dimethylated arginines in human plasma by high pressure liquid chromatography. J Chromatogr B 692:257-262
23. Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Böger RH, CREED Investigators (2002) Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62:339-345
24. Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D (2002) Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13:170-176
25. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23:1455-1459
26. Calver A, Collier J, Leone A, Moncada S, Vallance P (1993) Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers. J Hum Hypertens 7:193-194
27. Xiao S, Wagner L, Schmidt RJ, Baylis C (2001) Circulating eNOS inhibitory factor in some patients with chronic renal disease. Kidney Int 59:1466-1472
28. Tojo A, Welch WJ, Bremer V, Kimoto M, Kimura K, Omata M, Ogawa T, Vallance P, Wilcox CS (1997) Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 52:1593-1601
29. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, Whitley GST, Vallance P (1996) Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 119:1533-1540
30. Jones LC, Tran CT, Leiper JM, Hingorani AD, Vallance P (2003) Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells. Biochem Biophys Res Commun 310:836-843
31. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP (1998) Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842-1847
32. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP (1999) Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99:3092-3095
33. Himmelfarb J (2004) Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Semin Dial 17:449-454
34. G-dimethylarginine. Acta Physiol Scand 167:145-150
35. Kone BC, Kuncewicz T, Zhang W, Yu ZY (2003) Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol 285:F178-F190
36. Roczniak A, Levine DZ, Burns KD (2000) Localization of protein inhibitor of neuronal nitric oxide synthase in rat kidney. Am J Physiol 278:F702-F707
37. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, Corna D, Zoja C, Cavallotti D, Remuzzi G (1997) Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 52:171-181
38. Vaziri ND, Ni Z, Wang XQ, Oveisi F, Zhou XL (1998) Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol 274:F642-F649
39. Szabo A, Wagner L, Erdely A, Lau K, Baylis C (2003) Renal neuronal nitric oxide synthase protein expression as a marker of renal function. Kidney Int 64:1765-1771
40. Wagner L, Riggleman A, Erdely A, Couser W, Baylis C (2002) Reduced NOS activity in rats with chronic renal disease due to glomerulonephritis. Kidney Int 62:532-536
41. Müller V, Szabó A, Baylis C (2002) Changes in renal endothelial and neuronal nitric oxide synthase (eNOS, nNOS) protein abundance in chronic allograft rejection in rats. J Am Soc Nephrol 13:558A
42. Fitzgibbon WR, Greene EL, Grewal JS, Hutchison FN, Self SE, Latten SY, Ullian ME (1999) Resistance to remnant nephropathy in the Wistar-Furth rat. J Am Soc Nephrol 10:814-821
43. Müller V, Engels K, Baylis C (2003) Chronic inhibition of nitric oxide synthase (NOS) renders the C57BL6 mouse susceptible to the development of chronic renal disease. J Am Soc Nephrol 14:625A